A 10 Year Prospective Followup of Patients with Rheumatoid Arthritis – (01-03-02)



A 10 Year Prospective Followup of Patients with Rheumatoid Arthritis

Let’s look at this…very toxic drugs, significant side effects, and NOW we find out that drugs for RA actually make the patient worse in the long run? While it does not surprise me, be really need to wake up in medicine. The “first do no harm” mantra seems to have fallen by the wayside. Treatment for arthritis with NSAIDs has shown progression of osteoarthritis and now this. What makes this article even more dis-concerning is that there are effective, safe natural methods for managing many autoimmune disorders. Lifestyle changes, elimination diets and unrefined diets are some of the most powerful medicines for these conditions. There are still, however, many patients who are not willing to even listen to take of lifestyle changes. I had a patient with scleroderma who took 15 minutes for her and her oxygen tank to make it the 200 yards from the parking lot to my table. Quality of life was zero and progression of the disease was imminent. And yet she thought I was crazy for suggesting that lifestyle changes may have an impact on her condition. No other doctor she had seen had mentioned this before, so it couldn’t possibly be true coming from a chiropractor… Abstract:

 

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Arthritis, NSAIDs Dangerous
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”